Research to date for regenerative medicine has been extremely promising. Small studies in humans have shown excellent benefits of platelet rich plasma therapy, bone marrow and amniotic derived stem cell injections for several musculoskeletal conditions.
This includes degenerative arthritis, tendonitis in several areas such as the shoulder, knee, ankle, along with helping heal ligament injuries more completely and faster than what occurs naturally.
R3 is working with Beverly Hills Stem Cell & Surgical Institute Medical Director Dr. Raj to further our knowledge when it comes to the benefits of musculoskeletal stem cell therapies. Several projects are in the works. Patient treatment is not randomized, therefore, each patient will in fact receive the stem cell therapy. No placebo is utilized, which places patients’ minds at ease when undergoing treatment.
The research projects are industry subsidized, which is able to substantially defray the patient cost of treatment. It does not completely cover the cost of treatment, however, stem cell therapies at Beverly Hills Orthopedic Institute routinely cost about 30% less than other centers as a result.
It is truly a very exciting time for regenerative medicine, with its potential to repair and heal injury from degenerative arthritis and soft tissue injury. Individuals ranging from professional and amateur athletes, executives, weekend warriors, grandparents, manual laborers and students are able to now reap the benefits of these cutting-edge treatment options with the program R3 has set up at Beverly Hills Stem Cell & Surgical Institute.